ARTICLE | Clinical News
Hepatect CP regulatory update
February 22, 2010 8:00 AM UTC
Biotest said that in November 2009 the EC approved an MAA for subcutaneous Zutectra human hepatitis B immunoglobulin to prevent HBV re-infection in HBV-DNA negative patients >=6 months after liver tra...